JAK2 V617F mutation positive primary myelofibrosis with concomitant t(9;11;22)(q34;p15;q11.2) but no BCR/ABL fusion

被引:0
|
作者
Wing-Yan Au
Thomas S. K. Wan
Edmond S. K. Ma
机构
[1] Queen Mary Hospital,Department of Medicine
[2] Queen Mary Hospital,Department of Pathology
[3] Hong Kong Sanatorium & Hospital,Department of Pathology
来源
关键词
Imatinib; Tyrosine Kinase Inhibitor; Tenofovir; Chronic Myelogenous Leukemia; Imatinib Mesylate;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:435 / 437
页数:2
相关论文
共 50 条
  • [41] Successful treatment with azacitidine for the simultaneous occurrence of multiple myeloma and acute myeloid leukemia with concomitant del(5q) and the JAK2 V617F mutation
    Satoko Oka
    Kazuo Ono
    Masaharu Nohgawa
    Annals of Hematology, 2017, 96 : 1411 - 1413
  • [42] Extramedullary T-lymphoid blast crisis of an ETV6/ABL1-positive myeloproliferative neoplasm with t(9;12)(q34;p13) and t(7;14)(p13;q11.2)
    Yamamoto, Katsuya
    Yakushijin, Kimikazu
    Nakamachi, Yuji
    Miyata, Yoshiharu
    Sanada, Yukinari
    Tanaka, Yasuhiro
    Okamura, Atsuo
    Kawano, Seiji
    Hayashi, Yoshitake
    Matsuoka, Hiroshi
    Minami, Hironobu
    ANNALS OF HEMATOLOGY, 2014, 93 (08) : 1435 - 1438
  • [43] Extramedullary T-lymphoid blast crisis of an ETV6/ABL1-positive myeloproliferative neoplasm with t(9;12)(q34;p13) and t(7;14)(p13;q11.2)
    Katsuya Yamamoto
    Kimikazu Yakushijin
    Yuji Nakamachi
    Yoshiharu Miyata
    Yukinari Sanada
    Yasuhiro Tanaka
    Atsuo Okamura
    Seiji Kawano
    Yoshitake Hayashi
    Hiroshi Matsuoka
    Hironobu Minami
    Annals of Hematology, 2014, 93 : 1435 - 1438
  • [44] A rare case of a three way complex variant positive Philadelphia translocation involving chromosome (9;11;22)(q34;p15;q11) in chronic myeloid leukemia: A case report
    Asif, Muhammad
    Hussain, Abrar
    Rasool, Mahmood
    ONCOLOGY LETTERS, 2016, 12 (03) : 1986 - 1988
  • [45] The First Case Report of JAK2-BCR-PPP1R32 Fusion Genes Because of a Translocation (9;22;11) (p24;q11.2;q13) in a Patient With Myeloproliferative Neoplasm
    Xie, Huan
    Zhao, Zhongyue
    Zeng, Dongfeng
    ANNALS OF LABORATORY MEDICINE, 2023, 43 (03) : 295 - 298
  • [46] Incidentally-detected t(9;22)(q34;q11)/BCR-ABL1- positive clone developing into chronic phase chronic myeloid leukaemia after four years of dormancy
    Morita, Kiyomi
    Nakamura, Fumihiko
    Taoka, Kazuki
    Satoh, Yumiko
    Iizuka, Hiromitsu
    Masuda, Akiko
    Seo, Sachiko
    Nannya, Yasuhito
    Yatomi, Yutaka
    Kurokawa, Mineo
    BRITISH JOURNAL OF HAEMATOLOGY, 2016, 174 (05) : 815 - 817
  • [47] Induction of t(9;22) (q34;q11) in Bone Marrow-Derived HSPCs Via CRISPR/Cas9 to Reveal the Differences of the Leukemogenic Properties of p210BCR/ABL1 and p185BCR/ABL1
    Radszuweit, Pia
    Korkmaz, Fulya
    Mankel, Barbara
    Fitzel, Rahel
    Erkner, Estelle
    Keppeler, Hildegard
    Lengerke, Claudia
    Schneidawind, Dominik
    Schneidawind, Corina
    BLOOD, 2022, 140 : 5879 - 5879
  • [48] Bullous Sweet syndrome in a patient with t(9;22)(q34;q11)-positive chronic myeloid leukemia treated with the tyrosine kinase inhibitor nilotinib - Interphase cytogenetic detection of BCR-ABL-positive lesional cells
    Kaune, Kjell Matthias
    Baumgart, Mario
    Gesk, Stefan
    Mitteldorf, Christina
    Baesecke, Joerg
    Glass, Bertram
    Haase, Detlef
    Siebert, Reiner
    Ghadimi, Michael
    Neumann, Christine
    Emmert, Steffen
    ARCHIVES OF DERMATOLOGY, 2008, 144 (03) : 361 - 364
  • [49] A case of pediatric B-Lymphoblastic leukemia presenting with a t(9;12)(p24;q11.2) involving JAK2 and concomitant MLL rearrangement with apparent insertion at 6q27
    Tirado C.A.
    Shabsovich D.
    DeNicola M.
    Rao D.
    Yang L.
    Garcia R.
    Rao N.
    Biomarker Research, 1 (1)
  • [50] NEW TRANSLOCATIONS [T(6,15)(P25,Q22) AND T(6,19)(Q16,Q13.3)] WITH T(9,22)(Q34,Q11) IN A PH-POSITIVE CHRONIC MYELOGENOUS LEUKEMIA
    MACERA, MJ
    SANCHEZ, MA
    ELIZALDE, AM
    GOGINENI, SK
    VERMA, RS
    CANCER GENETICS AND CYTOGENETICS, 1994, 72 (01) : 65 - 67